Palouse Capital Management Inc. decreased its stake in UnitedHealth Group Inc (NYSE:UNH) by 0.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,839 shares of the healthcare conglomerate’s stock after selling 84 shares during the quarter. Palouse Capital Management Inc.’s holdings in UnitedHealth Group were worth $3,377,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Canton Hathaway LLC purchased a new stake in UnitedHealth Group during the 1st quarter worth about $36,000. Truvestments Capital LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $42,000. Coastal Capital Group Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter worth about $45,000. Creative Financial Designs Inc. ADV increased its holdings in shares of UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares during the period. Finally, Capital Advisors Ltd. LLC increased its holdings in shares of UnitedHealth Group by 235.7% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after purchasing an additional 165 shares during the period. Hedge funds and other institutional investors own 85.37% of the company’s stock.
Several analysts have recently weighed in on the stock. Citigroup upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their target price for the company from $247.00 to $280.00 in a research report on Friday, May 10th. Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Raymond James lifted their target price on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a research report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $295.06.
UNH stock traded down $1.21 during trading hours on Friday, reaching $231.73. The stock had a trading volume of 210,169 shares, compared to its average volume of 3,167,423. The stock has a market capitalization of $227.59 billion, a PE ratio of 17.99, a price-to-earnings-growth ratio of 1.28 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The stock has a 50-day simple moving average of $251.08 and a 200 day simple moving average of $247.23. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the company posted $3.14 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is currently 33.54%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is the downside to momentum investing?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.